Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
about
Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOPLoss of TNFAIP3 enhances MYD88-driven signaling in non-Hodgkin lymphomaCirculating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphomaNew Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid Malignancies
P2860
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
description
article
@en
im April 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2018
@uk
name
Molecular subtypes of diffuse ...... ogenic mechanisms and outcomes
@en
Molecular subtypes of diffuse ...... ogenic mechanisms and outcomes
@nl
type
label
Molecular subtypes of diffuse ...... ogenic mechanisms and outcomes
@en
Molecular subtypes of diffuse ...... ogenic mechanisms and outcomes
@nl
prefLabel
Molecular subtypes of diffuse ...... ogenic mechanisms and outcomes
@en
Molecular subtypes of diffuse ...... ogenic mechanisms and outcomes
@nl
P2093
P50
P1433
P1476
Molecular subtypes of diffuse ...... ogenic mechanisms and outcomes
@en
P2093
Aaron R Thorner
Adam A Tracy
Amaro Taylor-Weiner
Andreas Rosenwald
Andrew J Dunford
Anne J Novak
Atanas Kamburov
Bjoern Chapuy
Caroline A Coughlin
P2888
P304
P356
10.1038/S41591-018-0016-8
P407
P50
P577
2018-04-30T00:00:00Z